Vertex faces pressure from potential U.S. drug pricing reforms and tariffs. Click here to find out why VRTX stock is a Hold.
Zacks Investment Research on MSN
Vertex Plunges Around 24% in Six Months: How to Play the Stock
Vertex Pharmaceuticals Incorporated VRTX stock has declined 23.6% in the past six months, mainly due to recent pipeline ...
The FDA granted breakthrough therapy designation to a Vertex Pharmaceuticals kidney disease drug.
Trail of Bits showed how crafted images could manipulate systems, including Gemini CLI, Vertex AI Studio, Google Assistant on Android, and Gemini’s web interface. In one case, Google Calendar data was ...
Cerebras’s hosted Qwen3 Coder service promised to be the Claude replacement many developers craved. We’re losing hope.
CRISPR Therapeutics AG is a long-term buy despite slow Casgevy uptake. Click for my updated look at CRSP earnings and the ...
The auto industry is flashing warning lights on the state of the U.S. economy. Automakers' profits are getting squeezed by tariffs. A subprime auto lender recently collapsed, and some car retailers ...
Adam Nemeroff does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond ...
Ralph Lauren launches 'Ask Ralph,' an AI-powered digital stylist within its app, developed with Microsoft Azure OpenAI, ...
Acumatica has announced the general availability of its 2025 R2 ERP Platform. The R2 release features new and updated enhancements that improve usability, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results